Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Precision medicine approaches in diabetic cardiomyopathy: from molecular mechanisms to personalized therapeutic strategies
Vaibhavkumar Patel; Kinjal Patel; Bhakti Patel; Drashti Patel; Aarti KushwahaShow moreShow less
Head of Department of Pharmacology and Pharmacy Practice, Saraswati Institute of Pharmaceutical Science, Gandhinagar, Gujarat, India; Department of Pharmacy, Sumandeep Vidyapeeth, Vadodara, Gujarat, India; Department of Pharmacology and Pharmacy Practice, Saraswati Institute of Pharmaceutical Science, Gandhinagar, Gujarat, India; Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, India; Clinical Research Co-ordinator, RSW Health, Ahmedabad, Gujarat, IndiaShow moreShow less
Electrophysiological remodeling in the hypertrophic cardiomyopathy MYBPC3 R943X mutant in human iPSC-derived cardiomyocytes and modulation by IKto-targeting drugs
Mena Abdelsayed; Efthimios Tim Gianitsos; Alice Yu; Mark MercolaShow moreShow less
Lankenau Institute for Medical Research, Wynnewood, PA, USA; Advanced Micro Devices, Inc., San Diego, CA, USA; OncoCardia Corporation, Belmont, CA, USA; Stanford Cardiovascular Institute, Stanford, CA, USAShow moreShow less
S-nitrosylation of CaMKII Cys273 suppresses CaMKII activation and mobility within cardiac myocytes
Chidera C. Alim; Wei-Lun Hsiao; Christopher Y. Ko; Julie Bossuyt; Donald M. BersShow moreShow less
Department of Pharmacology, University of California, Davis, Davis, CA, United States of AmericaShow moreShow less
Inhibition of CDK1 attenuates cardiac remodeling via suppression of fibroblast-derived TGF-β1
Taishi Yamamoto; Shouji Matsushima; Eri Noda; Kosuke Okabe; Masashi Sada; Nobuyuki Enzan; Yoshitomo Tsutsui; Ryo Miyake; Ryohei Nishimura; Takayuki Toyohara; Hiroko Deguchi Miyamoto; Akihito Ishikita; Soichiro Ikeda; Tomonori Tadokoro; Masataka Ikeda; Keisuke Shinohara; Toru Hashimoto; Daiki Setoyama; Yuya Kunisaki; Shintaro Kinugawa; Hiroyuki Tsutsui; Kohtaro AbeShow moreShow less
Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan; Division of Cardiovascular Medicine, Research Institute of Angiocardiology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan; Department of Clinical Laboratory, Kyushu University Hospital, Fukuoka, Japan; Department of Cardiovascular Medicine, NHO Fukuoka National Hospital, Fukuoka, JapanShow moreShow less
Multi-omic analysis reveals maturation programs in human pluripotent stem cell-derived cardiomyocytes during long-term culture
Austin K. Feeney; Aaron D. Simmons; Elizabeth F. Bayne; Yanlong Zhu; Chanhyung Park; Claire J. Peplinski; Fathima Shabnam; Xiaotian Zhang; Jianhua Zhang; Melissa R. Pergande; Timothy J. Kamp; Ying Ge; Sean P. PalecekShow moreShow less
Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA; Medical Scientist Training Program, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA; Department of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA; Department of Chemistry, University of Wisconsin-Madison, Madison, WI 53706, USA; Department of Cell and Regenerative Biology, University of Wisconsin-Madison, Madison, WI 53705, USA; Human Proteomics Program, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USAShow moreShow less
Icosapent ethyl activates GPR120 to improve post-myocardial infarction cardiac remodeling by suppressing CXCR3+ inflammatory cells
Lu Liu; Wenhui Niu; Yumeng Jia; Qun Zhang; Tangyu Dai; Dingwei Li; Shuang Song; Yan Ma; Jingjing Wang; Huanling Yu; Guoyou Liu; Jie Du; Lei WangShow moreShow less
Department of Nutrition and Food Hygiene, Beijing Key Laboratory of Environment and Aging, School of Public Health, Capital Medical University, Beijing 100069, China; Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, No. 1 Dongjiaomin Lane, Dongcheng District, Beijing 100730, China; National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention, Beijing 100050, China; Department of Laboratory Animals, Capital Medical University, Beijing 100069, China; Department of Cardiology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China; Institute for Biological Therapy, Henan Academy of Medical Science, Zhengzhou, Henan 451163, China; Beijing Anzhen Hospital, Capital Medical University; The Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education; Beijing Collaborative Innovative Research Center for Cardiovascular Diseases; Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing 100029, China; The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing 100029, ChinaShow moreShow less
FAQ
How long does JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY take to review a manuscript?
As of 2026-11-13, CrushSCI has 15 complete review records for JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. The fastest paper went from submission to acceptance in 18 days (Precision medicine approaches in diabetic cardiomyopathy: from molecular mechanisms to personalized therapeutic strategies, received 2026-10-02, accepted 2026-10-20); the slowest took 316 days. The average is 170.5 days and the median is 160 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
